| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.243 | 42 | 90 | 0 | 253 | 2.698 | 671 | 1.828 | 970 | 965 |
| Total Income - EUR | 3.243 | 42 | 90 | 0 | 691 | 2.698 | 671 | 1.828 | 970 | 965 |
| Total Expenses - EUR | 2.854 | 1.082 | 283 | 97 | 152 | 506 | 828 | 86 | 188 | 89 |
| Gross Profit/Loss - EUR | 389 | -1.041 | -193 | -97 | 539 | 2.192 | -157 | 1.741 | 783 | 876 |
| Net Profit/Loss - EUR | 292 | -1.042 | -195 | -97 | 518 | 2.112 | -170 | 1.688 | 660 | 757 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medcomplete Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4.709 | 3.801 | 3.541 | 1.435 | 248 | 1.957 | 25 | 1.551 | 2.216 | 2.958 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 896 | 430 | 256 | 251 | 246 | 1.275 | 0 | 0 | 81 | 0 |
| Cash | 3.814 | 3.370 | 3.285 | 1.183 | 1 | 682 | 25 | 1.551 | 2.135 | 2.958 |
| Shareholders Funds | -657 | -1.692 | -1.859 | -1.922 | -1.366 | 772 | -427 | 1.260 | 1.916 | 2.662 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.366 | 5.493 | 5.400 | 3.356 | 1.614 | 1.185 | 451 | 291 | 299 | 295 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Medcomplete Srl